Literature DB >> 8417077

Can restenosis after coronary angioplasty be predicted from clinical variables?

W S Weintraub1, A S Kosinski, C L Brown, S B King.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether variables shown to correlate with restenosis in one group (learning group) could be shown to predict recurrent stenosis in a second group (validation group).
BACKGROUND: Restenosis remains a critical limitation after percutaneous transluminal coronary angioplasty. Although several clinical variables have been shown to correlate with restenosis, there are few data concerning attempts to predict recurrent stenosis.
METHODS: The source of data was the clinical data base at Emory University. Patients who had had previous coronary surgery and patients who underwent coronary angioplasty in the setting of acute myocardial infarction were excluded. A total of 4,006 patients with angiographic restudy after successful angioplasty were identified. They were classified into a learning group of 2,500 patients and a validation group of 1,506 patients. The correlates of restenosis in the learning group were determined by stepwise logistic regression, and a model was developed to predict the probability of restenosis and was tested in the validation group. By using various cut points for the predicted probability of restenosis, a receiver operating characteristic curve was created. Goodness of fit of the model was evaluated by comparing average predicted probabilities with average observed probabilities within subgroups on the basis of risk level determined by linear regression analysis.
RESULTS: In the learning group 1,145 patients had restenosis and 1,355 did not. Correlates of restenosis were severe angina, severe diameter stenosis before angioplasty, left anterior descending coronary artery dilation, diabetes, greater diameter stenosis after angioplasty, hypertension, absence of an intimal tear, eccentric morphology and older patient age. The model derived from the learning group was used to predict restenosis in the validation group. By varying the cut point for the predicted probability of restenosis above which restenosis is diagnosed and below which it is not, a receiver operating characteristic curve was created. The curve was close to the line of identity, reflecting a poor predictive ability. However, the model was shown to fit well with the predicted probability of restenosis correlating well with the observed probability (r = 0.98, p = 0.0001).
CONCLUSIONS: Clinical variables provide limited ability to predict definitively whether a particular patient will have restenosis. However, the current model may be used to predict the probability of restenosis, with some uncertainty, at least in well characterized patients who have already had angioplasty.

Entities:  

Mesh:

Year:  1993        PMID: 8417077     DOI: 10.1016/0735-1097(93)90711-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Hybrid revascularization feasibility in minimally invasive direct coronary artery bypass grafting combined with percutaneous transluminal coronary angioplasty in patients with acute coronary syndrome and multivessel disease.

Authors:  Y Matsumoto; M Endo; F Kasashima; Y Abe; I Kosugi; Y Hirano; H Sasaki; T Ueyama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

4.  Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Kan Kajimoto; Naozumi Kubota; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

Review 5.  Novel QCA methodologies and angiographic scores.

Authors:  Vivian G Ng; Alexandra J Lansky
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

6.  Myocardial "hybrid" revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study.

Authors:  T Wittwer; J Cremer; P Boonstra; J Grandjean; M Mariani; A Mügge; H Drexler; P den Heijer; E R Leitner; A Hepp; M Wehr; A Haverich
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 7.  Restenosis after PCI. Part 1: pathophysiology and risk factors.

Authors:  J Wouter Jukema; Jeffrey J W Verschuren; Tarek A N Ahmed; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-09-13       Impact factor: 32.419

Review 8.  Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

9.  Long-term follow-up of coronary angioplasty in patients with diabetes compared with nondiabetics.

Authors:  B R G Brueren; J M Ten Berg; J C Kelder; M J Suttorp; E G Mast; E Bal; S M P G Ernst; H W T Plokker
Journal:  Neth Heart J       Date:  2004-04       Impact factor: 2.380

10.  Rationale and design of the randomized, multicenter, cilostazol for RESTenosis (CREST) trial.

Authors:  John S Douglas; William S Weintraub; David Holmes
Journal:  Clin Cardiol       Date:  2003-10       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.